Show simple item record

dc.contributor.authorWicaksono, Yudi
dc.contributor.authorWisudyaningsih, Budipratiwi
dc.contributor.authorSiswoyo, Tri Agus
dc.date.accessioned2017-01-23T07:50:37Z
dc.date.available2017-01-23T07:50:37Z
dc.date.issued2017-01-23
dc.identifier.isbn978-602-74798-8-3
dc.identifier.urihttp://repository.unej.ac.id/handle/123456789/79095
dc.descriptionProceeding 1st International Conference on Medicine and Health Sciences (ICMHS) 2016en_US
dc.description.abstractCocrystal is a relatively new solid form of active pharmaceutical ingredient that offers an alternative platform in improving physicochemical properties of active pharmaceutical ingredients Padrela et al., 2009; Mashhadi et al., 2004. Cocrystal is defined as a stoichiometric multi-component system connected by non-covalent interactions where all the components neutral and solid under ambient conditions Thakuria et al., 2013. Cocrystal can be constructed through interaction hydrogen bonding, pi-stacking, and van der Waals forces  Mashhadi et al., 2004. A pharmaceutical cocrystal is composed of an API and an appropriate coformer as carboxylic acids and amides Qiao et al., 2011. Cocrystallization of active pharmaceutical ingredient is an opportunity for enhancement of important physiochemical properties of an active pharmaceutical ingredient without changing its molecular structure Maeno et al., 2014.en_US
dc.language.isoenen_US
dc.subjectCOCRYSTALen_US
dc.subjectATORVASTATIN CALCIUMen_US
dc.subjectMALONIC ACIDen_US
dc.titleCOCRYSTAL OF ATORVASTATIN CALCIUM – MALONIC ACIDen_US
dc.typeProsidingen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record